医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
OCUL · OCULAR THERAPEUTIX, INC
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
OCULAR THERAPEUTIX, INC（OCUL）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $568K；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-13。
买入 Bought—
卖出 Sold$568K
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-08 | Anderman Todd Chief Legal Officer | 卖出 Sell | 11,984 | $7.29 | $87K | SEC |
| 2026-10-02 | Heier Jeffrey S. Chief Scientific Officer | 卖出 Sell | 10,869 | $7.05 | $77K | SEC |
| 2026-10-02 | Kaiser Peter Chief Development Officer | 卖出 Sell | 9,990 | $7.05 | $70K | SEC |
| 2026-08-31 | Notman Donald Chief Operating Officer | 卖出 Sell | 1,099 | $10.24 | $11K | SEC |
| 2026-08-24 | Dugel Pravin Director, See Remarks | 卖出 Sell | 21,649 | $10.77 | $233K | SEC |
| 2026-08-24 | Heier Jeffrey S. Chief Scientific Officer | 卖出 Sell | 3,296 | $10.78 | $36K | SEC |
| 2026-08-24 | Kaiser Peter Chief Development Officer | 卖出 Sell | 3,035 | $10.77 | $33K | SEC |
| 2026-08-24 | Nayak Sanjay Chief Strategy Officer | 卖出 Sell | 1,897 | $10.78 | $20K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-10-08 | Anderman Todd Officer | 11,984 | $87K | |
| 2026-10-02 | Heier Jeffrey S. Officer | 10,869 | $77K | |
| 2026-10-02 | Kaiser Peter Officer | 9,990 | $70K | |
| 2026-08-31 | Notman Donald Officer | 1,099 | $11K | |
| 2026-08-24 | Dugel Pravin Officer | 21,649 | $233K | |
| 2026-08-24 | Heier Jeffrey S. Officer | 3,296 | $36K | |
| 2026-08-24 | Kaiser Peter Officer | 3,035 | $33K | |
| 2026-08-24 | Nayak Sanjay Officer | 1,897 | $20K |
内部人 Insiders
Anderman Todd、Heier Jeffrey S.、Kaiser Peter、Notman Donald、Dugel Pravin、Nayak Sanjay